Parallel Advisors’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.6K Buy
527
+58
+12% +$1.34K ﹤0.01% 2804
2026
Q1
$9.65K Buy
469
+155
+49% +$3.49K ﹤0.01% 2774
2025
Q4
$7.45K Buy
314
+79
+34% +$1.92K ﹤0.01% 2716
2025
Q3
$5.85K Sell
235
-46
-16% -$990 ﹤0.01% 2722
2025
Q2
$6.46K Buy
281
+11
+4% +$255 ﹤0.01% 2648
2025
Q1
$6.06K Buy
270
+69
+34% +$1.6K ﹤0.01% 2610
2024
Q4
$3.93K Sell
201
-32
-14% -$634 ﹤0.01% 2725
2024
Q3
$4.24K Buy
233
+18
+8% +$343 ﹤0.01% 2669
2024
Q2
$3.74K Buy
215
+83
+63% +$1.47K ﹤0.01% 2617
2024
Q1
$2.59K Sell
132
-683
-84% -$14.4K ﹤0.01% 2744
2023
Q4
$18.8K Sell
815
-9,289
-92% -$208K ﹤0.01% 1989
2023
Q3
$232K Sell
10,104
-6
-0.1% -$153 0.01% 723
2023
Q2
$264K Buy
10,110
+13
+0.1% +$343 0.01% 666
2023
Q1
$279K Sell
10,097
-108
-1% -$2.85K 0.01% 634
2022
Q4
$232K Buy
10,205
+205
+2% +$5.71K 0.01% 636
2022
Q3
$341K Buy
+10,000
New +$370K 0.02% 492

Other funds holding PRVA

Parallel Advisors's PRVA Position: Q2 2026 in Review

Parallel Advisors increased its Privia Health (PRVA) stake by 12% in Q2 2026, buying an estimated $1.34K and bringing the position to 527 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2804.

Parallel Advisors first reported a position in PRVA in Q3 2022 and has held it in 16 quarters since. The position peaked at $341K in Q3 2022. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Parallel Advisors held 527 shares of Privia Health worth $13.6K as of Q2 2026.
  • Parallel Advisors bought 58 Privia Health shares in Q2 2026, an estimated $1.34K.
  • Privia Health made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2804 holding.
  • Parallel Advisors first reported a position in Privia Health in Q3 2022 and has held it in 16 quarters since.
  • Parallel Advisors's Privia Health position peaked at $341K in Q3 2022.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.